Shares of Align Technology Inc (NASDAQ:ALGN) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results.



Align Tech reported quarterly earnings of $3.29 per share which beat the analyst consensus estimate of $2.97 per share. The company reported quarterly sales of $1.047 billion which beat the analyst consensus estimate of $1.033 billion.



Align Technology shares jumped 10.4% to $178.13 in the pre-market trading session.



Here are some other stocks moving in pre-market trading.



<h3>Gainers</h3>



<ul>
<li>CytoMed Therapeutics Ltd (NASDAQ:GDTC) gained 41.2% to $1.20 in pre-market trading.</li>



<li>C3is Inc (NASDAQ:CISS) gained 48% to $2.25 in pre-market trading following a Securities and Exchange Commission filing disclosing that Imperial Petroleum Inc. (NASDAQ:IMPP) owns 81.9% of the company.</li>



<li>Trident Digital Tech Holdings Ltd (NASDAQ:TDTH) shares rose 36.6% to $0.38 in pre-market trading after declining 8% on Wednesday.</li>



<li>DHI Group Inc (NYSE:DHX) rose 25.3% to $2.08 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.</li>



<li>Fibrobiologics Inc (NASDAQ:FBLG) gained 23.9% to $0.31 in pre-market trading after declining 10% on Wednesday.</li>



<li>XORTX Therapeutics Inc (NASDAQ:XRTX) gained 16.3% to $0.57 in pre-market trading. XORTX issued an update on acquisition of Renal Anti-Fibrotic Therapeutic program from Vectus Biosystems.</li>



<li>American Superconductor Corp (NASDAQ:AMSC) gained 15.1% to $31.76 in pre-market trading after the company reported better-than-expected third-quarter financial results.</li>



<li>Kelly Services Inc (NASDAQ:KELYA) gained 14% to $12.30 in pre-market trading.</li>



<li>Phibro Animal Health Corp (NASDAQ:PAHC) shares jumped 13.9% to $46.70 in pre-market trading after the company reported better-than-expected second-quarter financial results and raised its FY26 guidance.</li>
</ul>



<h3>Losers</h3>



<ul>
<li>LifeVantage Corp (NASDAQ:LFVN) fell 26% to $4.11 in pre-market trading after the company reported worse-than-expected second-quarter sales results and cut its FY26 guidance below estimates.</li>



<li>Cerence Inc (NASDAQ:CRNC) dipped 18.4% to $8.80 in pre-market trading after the company reported mixed first-quarter financial results and issued FY25 adjusted EPS guidance below estimates.</li>



<li>Park Ha Biological Technology Co Ltd (NASDAQ:BYAH) fell 17% to $0.083 in pre-market trading after gaining 27% on Wednesday.</li>



<li>Zhongchao Inc (NASDAQ:ZCMD) fell 15.8% to $0.32 in pre-market trading after declining 2% on Wednesday.</li>



<li>Orangekloud Technology Inc (NASDAQ:ORKT) shares dipped 15.3% to $0.95 in pre-market trading after announcing Nasdaq delisting determination letter.</li>



<li>Wolfspeed Inc (NYSE:WOLF) tumbled 12.8% to $15.00 in pre-market trading after the company reported worse-than-expected second-quarter financial results and issued third-quarter sales guidance below estimates.</li>



<li>Julong Holding Ltd (NASDAQ:JLHL) fell 7.5% to $4.52 in pre-market trading after dipping  more than 15% on Wednesday</li>



<li>Qualcomm Inc (NASDAQ:QCOM) declined 11.3% to $132.00 in pre-market trading after the company reported first-quarter financial results and issued second-quarter guidance below estimates.</li>



<li>Kemper Corp (NYSE:KMPR) fell 11% to $34.27 in pre-market trading after the company reported mixed quarterly financial results.</li>



<li>Fluence Energy Inc (NASDAQ:FLNC) dipped 10.6% to $25.90 in pre-market trading after the company reported mixed first-quarter financial results.</li>
</ul>



Photo via Shutterstock

CISS

Align Technology shares rose over 10% in pre-market trading after reporting Q4 earnings of $3.29 per share, surpassing estimates of $2.97. Sales also exceeded expectations at $1.047 billion. Other notable pre-market movers include CytoMed Therapeutics (+41.2%), C3is Inc (+48%), and DHI Group (+25.3%). Conversely, LifeVantage Corp fell 26% after disappointing sales results, while Qualcomm Inc declined 11.3% following mixed financial results and lower guidance.

benzinga_article

SPDR S&P Health Equip

C3is

VanEck Biotech ETF

iShares US Medical Devices

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

Health Care Select Sector SPDR

iShares Biotechnology ETF

ALPS Medical Breakthrough

Invesco Nasdaq Biotechnology ETF

Cytomed Therapeutics

Align

Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket